Survival in primary pulmonary hypertension. Validation of a prognostic equation.
about
Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series)Detection of elevated right ventricular extracellular volume in pulmonary hypertension using Accelerated and Navigator-Gated Look-Locker Imaging for Cardiac T1 Estimation (ANGIE) cardiovascular magnetic resonance.Recent trends in pulmonary arterial hypertensionA brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.Pulmonary hypertension for primary care providersCardiac-specific genetic inhibition of nuclear factor-κB prevents right ventricular hypertrophy induced by monocrotaline.Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?The right ventricle: biologic insights and response to diseaseQuantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the artDeterminants of right ventricular ejection fraction in pulmonary arterial hypertension.Pulmonary hypertension's variegated landscape: a snapshot.Circulatory power and ventilatory power over time under goal-oriented sequential combination therapy for pulmonary arterial hypertension.Dobutamine stress MRI in pulmonary hypertension: relationships between stress pulmonary artery relative area change, RV performance, and 10-year survival.Dynamic contrast-enhanced magnetic resonance imaging in patients with pulmonary arterial hypertension.Simvastatin as a treatment for pulmonary hypertension trial.Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy.Are hemodynamics surrogate end points in pulmonary arterial hypertension?Accurate and reproducible measurements of right ventricular function in daily practice.Plasma volume and outcome in pulmonary hypertension.Investigating cardiac MRI based right ventricular contractility as a novel non-invasive metric of pulmonary arterial pressure.Bone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation.Overview of current therapeutic approaches for pulmonary hypertension.Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.Prognostic effects of pulmonary hypertension in patients undergoing cardiac resynchronization therapy.Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy.Impaired Global Right Ventricular Longitudinal Strain Predicts Long-Term Adverse Outcomes in Patients with Pulmonary Arterial Hypertension.Right Heart Failure during Veno-Venous Extracorporeal Membrane Oxygenation for H1N1 Induced Acute Respiratory Distress Syndrome: Case Report and Literature Review.Chronic hypoxia induces right heart failure in caveolin-1-/- mice.Current treatment strategies for pulmonary arterial hypertension.Comparison of 18F-FDG uptake by right ventricular myocardium in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease.Pharmacotherapy for idiopathic pulmonary arterial hypertension during the past 25 years.Pulmonary vascular remodeling and right heart failure in pulmonary hypertension: future role of positron emission tomography in decoding the enigma.Novel therapeutic approaches to preserve the right ventricle.The right ventricle: biologic insights and response to disease: updated.Evaluation of right atrial function using right atrial speckle tracking analysis in patients with pulmonary artery hypertension.Deletion of Fn14 receptor protects from right heart fibrosis and dysfunctionRight ventricular ejection fraction during exercise as a predictor of mortality in patients awaiting lung transplantation: a cohort study.Updating clinical endpoint definitions.Pulmonary arterial hypertension: an overview.Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-1 dependent pathway in rats.
P2860
Q26825047-A3D68F06-0A56-45A9-AEDB-49ECEAB4088BQ30277881-E54BB028-45E2-432D-9AEA-27CFA8EAD850Q30475192-E5D5B024-FC32-405E-9CD3-CE89B17F6291Q30544892-356CE907-825D-4F20-99B5-8F396BF6CBC6Q33160056-F114CBD6-7B2B-4901-A1C8-24664D89A9F7Q33160867-5C9E9EF7-C2DA-4787-8961-560651565D76Q33532813-A37DA90F-73BA-47A6-B7A0-B2BCA4D23F90Q33578032-0F83A143-4B82-42DD-AD7C-E2CD53290FD2Q33587892-C3456E37-F782-4B6A-8F06-D1C01B1867ABQ33712182-A24A11AF-2BF5-4219-891D-62ECF9298245Q33738561-1C19D1DB-7AC0-4C7F-BA54-D51686D27239Q33788510-B3875009-C1E0-4238-8EA9-6F1C0B87C031Q33788527-07CCE19D-681D-45D9-9F5E-6FBE389451F0Q33805937-059821B9-D101-4EB0-87E3-63E75CDE5341Q33868613-412E1009-9A70-4B3A-B8BE-779F6895FE23Q34088723-9B2D9ED0-75D4-4CA4-B7B6-68E528927A65Q34098418-D6905CCE-DA3D-497C-9EFD-A297845EA793Q34317022-ABFC4737-2A31-4A7B-8B7A-E2DDB6A2D592Q34796843-CDE52131-4DB5-4C5F-9E47-47A9BBF487C5Q34849991-2E469602-FE64-4EA4-8005-6BDCDA904F02Q35311990-0778EE0C-E61A-4336-95D0-9122E63198D0Q35412362-4441A54D-192D-4376-847E-4630339E2FF5Q35552142-74A6B5A0-CB19-4806-AA13-1E9C45111848Q35667672-33153E1F-A39E-40C3-B309-E16ED34D9F94Q35792872-0541DD73-43ED-4113-B18A-A8EEE0F4BD0AQ35800709-C6D9556C-AA06-4983-BEFF-2613FC9F38C5Q35969128-9C15B2B5-BC08-4A5F-8715-DCE6838B47C8Q36042487-5505E942-65E8-4B6D-8693-4C728321714EQ36237720-CB11E655-5BA1-4840-BA32-4785E1190581Q36366099-2C11AF3E-48DE-43D5-A4B4-B9B290ADE90EQ36408727-C75D36BF-0571-461E-AA2B-3849417A5898Q36468672-CE265A38-A6F4-46AC-B7F1-2C5F569C86B2Q36619235-C90448EB-58AF-4D80-9563-9497271D6F3BQ36644859-F75C6563-3D1C-456D-A0F8-1D5E42E0E8B6Q36656133-668CFE87-DC37-4F3A-8D83-B280962761C5Q36683886-5F5D8FBC-29ED-4031-A3EC-51DB9C01336FQ36809795-FA95BE42-E34F-4EC0-B25E-0EE6FB0A0DE8Q36810813-6FA4F8BA-BD63-41A0-8C1A-A233D95A0CF0Q36834617-137C0EF6-03BB-43DC-B4D3-EEFE146E33CDQ37190566-F806FC7D-76B0-4A43-9104-6D99F66CB563
P2860
Survival in primary pulmonary hypertension. Validation of a prognostic equation.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Survival in primary pulmonary hypertension. Validation of a prognostic equation.
@en
Survival in primary pulmonary hypertension. Validation of a prognostic equation.
@nl
type
label
Survival in primary pulmonary hypertension. Validation of a prognostic equation.
@en
Survival in primary pulmonary hypertension. Validation of a prognostic equation.
@nl
prefLabel
Survival in primary pulmonary hypertension. Validation of a prognostic equation.
@en
Survival in primary pulmonary hypertension. Validation of a prognostic equation.
@nl
P2093
P356
P1433
P1476
Survival in primary pulmonary hypertension. Validation of a prognostic equation.
@en
P2093
Guerrero ML
Martínez-Guerra ML
Sandoval J
P304
P356
10.1161/01.CIR.89.4.1733
P407
P577
1994-04-01T00:00:00Z